Результаты поиска - Gudrun Piringer

  • Отображение 1 - 7 результаты of 7
Отмена результатов
  1. 1
    Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: A case report and literature review

    Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-... по Gudrun Piringer, Gudrun Piringer, Gudrun Piringer, Jörn Decker, Vera Trommet, Thomas Kühr, Thomas Kühr, Sonja Heibl, Sonja Heibl, Konrad Dörfler, Josef Thaler, Josef Thaler

    Опубликовано 2023-05-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  2. 2
    Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis

    Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis по Gudrun Piringer, Gudrun Piringer, Gudrun Piringer, Florian Ponholzer, Josef Thaler, Josef Thaler, Thomas Bachleitner-Hofmann, Holger Rumpold, Holger Rumpold, Alexander de Vries, Lukas Weiss, Lukas Weiss, Richard Greil, Richard Greil, Michael Gnant, Dietmar Öfner

    Опубликовано 2024-05-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  3. 3
    Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

    Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie) по Florian Huemer, Josef Thaler, Gudrun Piringer, Hubert Hackl, Lisa Pleyer, Clemens Hufnagl, Lukas Weiss, Richard Greil

    Опубликовано 2018-01-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  4. 4
    LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

    LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study по Gudrun Piringer, Gudrun Piringer, Thomas Gruenberger, Josef Thaler, Josef Thaler, Irene Kührer, Klaus Kaczirek, Friedrich Längle, Istvan Viragos-Toth, Arno Amann, Wolfgang Eisterer, Reinhold Függer, Johannes Andel, Angelika Pichler, Judith Stift, Lidija Sölkner, Michael Gnant, Dietmar Öfner

    Опубликовано 2023-08-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  5. 5
    Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study

    Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study по Gudrun Piringer MD, MSc, Bernhard Holzner MD, Beate Mayrbaeurl MD, Sonja Heibl MD, Monika Sztankay MD, Sophie Frantal, Michael Gnant MD, Josef Thaler MD

    Опубликовано 2020-07-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  6. 6
    Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

    Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment по Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, Gudrun Piringer, Georg Schreil, Jörn Decker, Karl J. Aichberger, Patrick Kirchweger, Josef Thaler, Andreas Petzer, Clemens A. Schmitt, Gerald W. Prager, Holger Rumpold

    Опубликовано 2023-09-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  7. 7
    Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort

    Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort по Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, Thomas Melchardt, Thomas Winder, Patrick Reimann, Jakob Riedl, Arno Amann, Wolfgang Eisterer, Franz Romeder, Gudrun Piringer, Aysegül Ilhan-Mutlu, Ewald Wöll, Richard Greil, Lukas Weiss

    Опубликовано 2022-01-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: